HEKBlue GLP-1 cells respond to human GLP-1 and other GLP1 receptor agonists, including Semaglutide, Orforglipron, Tirzepatide, and Retatrutide
Full results will appear within 14 days, lasting three to four months
All PlexusDx medications are produced by licensed 503A compounding pharmacies, require no insurance, carry no membership fees, and are HSA/FSA eligible
Plan for ongoing treatment rather than expecting permanent results from a finite course
Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study
Your dose may need to go up during treatment, but your price won'tPlexusDx maintains flat monthly pricing across all commitment tiers